パーキンソン病治療の世界市場：市場規模・現状・予測

• 英文タイトル：Global Parkinson's Disease Treatment Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9ST04991 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

※当調査レポートでは、パーキンソン病治療の世界市場について調査・分析し、パーキンソン病治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（レボドパ/カルビドパ、ドーパミン受容体作動薬、MAO阻害剤、COMT阻害剤、抗コリン作動薬）、用途別（病院、診療所）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のパーキンソン病治療市場動向 ・主要企業別マーケットシェア ・パーキンソン病治療の種類別市場規模2014-2019 （レボドパ/カルビドパ、ドーパミン受容体作動薬、MAO阻害剤、COMT阻害剤、抗コリン作動薬） ・パーキンソン病治療の用途別市場規模2014-2019 （病院、診療所） ・パーキンソン病治療の北米市場：主要企業・種類別/用途別市場規模 ・パーキンソン病治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・パーキンソン病治療の中国市場：主要企業・種類別/用途別市場規模 ・パーキンソン病治療の日本国内市場：主要企業・種類別/用途別市場規模 ・パーキンソン病治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・パーキンソン病治療のインド市場：主要企業・種類別/用途別市場規模 ・パーキンソン病治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （GSK、Merck、Novartis、Teva、Boehringer Ingelheim、Impax、Abbvie、Bausch Health、Lundbeck、Sun Pharmaceutical Industries、Wockhardt、Acadia Pharmaceuticals、UCB） ・パーキンソン病治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ...

Parkinson’s disease (PD) is a long-term degenerative disorder of the central nervous system that mainly affects the motor system.There is no cure for Parkinson’s disease, with treatment directed at improving symptoms. Initial treatment is typically with the antiparkinson medication levodopa (L-DOPA), with dopamine agonistsbeing used once levodopa becomes less effective. As the disease progresses and neurons continue to be lost, these medications become less effective while at the same time they produce a complication marked by involuntary writhing movements. Diet and some forms of rehabilitation have shown some effectiveness at improving symptoms.
In 2018, the global Parkinson’s Disease Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Parkinson’s Disease Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Parkinson’s Disease Treatment development in United States, Europe and China.

The key players covered in this study
GSK
Merck
Novartis
Teva
Boehringer Ingelheim
Impax
Abbvie
Bausch Health
Lundbeck
Sun Pharmaceutical Industries
Wockhardt
Acadia Pharmaceuticals
UCB

Market segment by Type, the product can be split into
Levodopa/carbidopa
Dopamine Receptor Agonists
MAO-Inhibitors
COMT-inhibitors
Anticholinergics

Market segment by Application, split into
Hospitals
Clinics

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Parkinson’s Disease Treatment status, future forecast, growth opportunity, key market and key players.
To present the Parkinson’s Disease Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Parkinson’s Disease Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

---

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Parkinson’s Disease Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Levodopa/carbidopa
1.4.3 Dopamine Receptor Agonists
1.4.4 MAO-Inhibitors
1.4.5 COMT-inhibitors
1.4.6 Anticholinergics
1.5 Market by Application
1.5.1 Global Parkinson’s Disease Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Parkinson’s Disease Treatment Market Size
2.2 Parkinson’s Disease Treatment Growth Trends by Regions
2.2.1 Parkinson’s Disease Treatment Market Size by Regions (2014-2025)
2.2.2 Parkinson’s Disease Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Parkinson’s Disease Treatment Market Size by Manufacturers
3.1.1 Global Parkinson’s Disease Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Parkinson’s Disease Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Parkinson’s Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Parkinson’s Disease Treatment Key Players Head office and Area Served
3.3 Key Players Parkinson’s Disease Treatment Product/Solution/Service
3.4 Date of Enter into Parkinson’s Disease Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Parkinson’s Disease Treatment Market Size by Type (2014-2019)
4.2 Global Parkinson’s Disease Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Parkinson’s Disease Treatment Market Size (2014-2019)
5.2 Parkinson’s Disease Treatment Key Players in United States
5.3 United States Parkinson’s Disease Treatment Market Size by Type
5.4 United States Parkinson’s Disease Treatment Market Size by Application

6 Europe
6.1 Europe Parkinson’s Disease Treatment Market Size (2014-2019)
6.2 Parkinson’s Disease Treatment Key Players in Europe
6.3 Europe Parkinson’s Disease Treatment Market Size by Type
6.4 Europe Parkinson’s Disease Treatment Market Size by Application

7 China
7.1 China Parkinson’s Disease Treatment Market Size (2014-2019)
7.2 Parkinson’s Disease Treatment Key Players in China
7.3 China Parkinson’s Disease Treatment Market Size by Type
7.4 China Parkinson’s Disease Treatment Market Size by Application

8 Japan
8.1 Japan Parkinson’s Disease Treatment Market Size (2014-2019)
8.2 Parkinson’s Disease Treatment Key Players in Japan
8.3 Japan Parkinson’s Disease Treatment Market Size by Type
8.4 Japan Parkinson’s Disease Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Parkinson’s Disease Treatment Market Size (2014-2019)
9.2 Parkinson’s Disease Treatment Key Players in Southeast Asia
9.3 Southeast Asia Parkinson’s Disease Treatment Market Size by Type
9.4 Southeast Asia Parkinson’s Disease Treatment Market Size by Application

10 India
10.1 India Parkinson’s Disease Treatment Market Size (2014-2019)
10.2 Parkinson’s Disease Treatment Key Players in India
10.3 India Parkinson’s Disease Treatment Market Size by Type
10.4 India Parkinson’s Disease Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Parkinson’s Disease Treatment Market Size (2014-2019)
11.2 Parkinson’s Disease Treatment Key Players in Central & South America
11.3 Central & South America Parkinson’s Disease Treatment Market Size by Type
11.4 Central & South America Parkinson’s Disease Treatment Market Size by Application

12 International Players Profiles
12.1 GSK
12.1.1 GSK Company Details
12.1.2 Company Description and Business Overview
12.1.3 Parkinson’s Disease Treatment Introduction
12.1.4 GSK Revenue in Parkinson’s Disease Treatment Business (2014-2019)
12.1.5 GSK Recent Development
12.2 Merck
12.2.1 Merck Company Details
12.2.2 Company Description and Business Overview
12.2.3 Parkinson’s Disease Treatment Introduction
12.2.4 Merck Revenue in Parkinson’s Disease Treatment Business (2014-2019)
12.2.5 Merck Recent Development
12.3 Novartis
12.3.1 Novartis Company Details
12.3.2 Company Description and Business Overview
12.3.3 Parkinson’s Disease Treatment Introduction
12.3.4 Novartis Revenue in Parkinson’s Disease Treatment Business (2014-2019)
12.3.5 Novartis Recent Development
12.4 Teva
12.4.1 Teva Company Details
12.4.2 Company Description and Business Overview
12.4.3 Parkinson’s Disease Treatment Introduction
12.4.4 Teva Revenue in Parkinson’s Disease Treatment Business (2014-2019)
12.4.5 Teva Recent Development
12.5 Boehringer Ingelheim
12.5.1 Boehringer Ingelheim Company Details
12.5.2 Company Description and Business Overview
12.5.3 Parkinson’s Disease Treatment Introduction
12.5.4 Boehringer Ingelheim Revenue in Parkinson’s Disease Treatment Business (2014-2019)
12.5.5 Boehringer Ingelheim Recent Development
12.6 Impax
12.6.1 Impax Company Details
12.6.2 Company Description and Business Overview
12.6.3 Parkinson’s Disease Treatment Introduction
12.6.4 Impax Revenue in Parkinson’s Disease Treatment Business (2014-2019)
12.6.5 Impax Recent Development
12.7 Abbvie
12.7.1 Abbvie Company Details
12.7.2 Company Description and Business Overview
12.7.3 Parkinson’s Disease Treatment Introduction
12.7.4 Abbvie Revenue in Parkinson’s Disease Treatment Business (2014-2019)
12.7.5 Abbvie Recent Development
12.8 Bausch Health
12.8.1 Bausch Health Company Details
12.8.2 Company Description and Business Overview
12.8.3 Parkinson’s Disease Treatment Introduction
12.8.4 Bausch Health Revenue in Parkinson’s Disease Treatment Business (2014-2019)
12.8.5 Bausch Health Recent Development
12.9 Lundbeck
12.9.1 Lundbeck Company Details
12.9.2 Company Description and Business Overview
12.9.3 Parkinson’s Disease Treatment Introduction
12.9.4 Lundbeck Revenue in Parkinson’s Disease Treatment Business (2014-2019)
12.9.5 Lundbeck Recent Development
12.10 Sun Pharmaceutical Industries
12.10.1 Sun Pharmaceutical Industries Company Details
12.10.2 Company Description and Business Overview
12.10.3 Parkinson’s Disease Treatment Introduction
12.10.4 Sun Pharmaceutical Industries Revenue in Parkinson’s Disease Treatment Business (2014-2019)
12.10.5 Sun Pharmaceutical Industries Recent Development
12.11 Wockhardt
12.12 Acadia Pharmaceuticals
12.13 UCB

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Parkinson's Disease Treatment Key Market Segments
Table Key Players Parkinson's Disease Treatment Covered
Table Global Parkinson's Disease Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Parkinson's Disease Treatment Market Size Market Share by Type 2014-2025
Figure Levodopa/carbidopa Figures
Table Key Players of Levodopa/carbidopa
Figure Dopamine Receptor Agonists Figures
Table Key Players of Dopamine Receptor Agonists
Figure MAO-Inhibitors Figures
Table Key Players of MAO-Inhibitors
Figure COMT-inhibitors Figures
Table Key Players of COMT-inhibitors
Figure Anticholinergics Figures
Table Key Players of Anticholinergics
Table Global Parkinson's Disease Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Parkinson's Disease Treatment Report Years Considered
Table Global Parkinson's Disease Treatment Market Size 2014-2025 (Million US$)
Figure Global Parkinson's Disease Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Parkinson's Disease Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Parkinson's Disease Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Parkinson's Disease Treatment Market Share by Regions 2014-2019
Figure Global Parkinson's Disease Treatment Market Share by Regions 2014-2019
Figure Global Parkinson's Disease Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Parkinson's Disease Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Parkinson's Disease Treatment Market Share by Manufacturers (2014-2019)
Figure Global Parkinson's Disease Treatment Market Share by Manufacturers in 2018
Table Global Parkinson's Disease Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Parkinson's Disease Treatment Product/Solution/Service
Table Date of Enter into Parkinson's Disease Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Parkinson's Disease Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Parkinson's Disease Treatment Market Size Share by Type (2014-2019)
Figure Global Parkinson's Disease Treatment Market Size Market Share by Type (2014-2019)
Table Global Parkinson's Disease Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Parkinson's Disease Treatment Market Size Share by Application (2014-2019)
Figure Global Parkinson's Disease Treatment Market Size Market Share by Application (2014-2019)
Figure Global Parkinson's Disease Treatment Revenue Market Share by Application in 2018
Figure United States Parkinson's Disease Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Parkinson's Disease Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Parkinson's Disease Treatment Market Share (2018-2019)
Table United States Parkinson's Disease Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Parkinson's Disease Treatment Market Share by Type (2014-2019)
Table United States Parkinson's Disease Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Parkinson's Disease Treatment Market Share by Application (2014-2019)
Figure Europe Parkinson's Disease Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Parkinson's Disease Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Parkinson's Disease Treatment Market Share (2018-2019)
Table Europe Parkinson's Disease Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Parkinson's Disease Treatment Market Share by Type (2014-2019)
Table Europe Parkinson's Disease Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Parkinson's Disease Treatment Market Share by Application (2014-2019)
Figure China Parkinson's Disease Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Parkinson's Disease Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Parkinson's Disease Treatment Market Share (2018-2019)
Table China Parkinson's Disease Treatment Market Size by Type (2014-20189) (Million US$)
Table China Parkinson's Disease Treatment Market Share by Type (2014-2019)
Table China Parkinson's Disease Treatment Market Size by Application (2014-2019) (Million US$)
Table China Parkinson's Disease Treatment Market Share by Application (2014-2019)
Figure Japan Parkinson's Disease Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Parkinson's Disease Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Parkinson's Disease Treatment Market Share (2018-2019)
Table Japan Parkinson's Disease Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Parkinson's Disease Treatment Market Share by Type (2014-2019)
Table Japan Parkinson's Disease Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Parkinson's Disease Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Parkinson's Disease Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Parkinson's Disease Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Parkinson's Disease Treatment Market Share (2018-2019)
Table Southeast Asia Parkinson's Disease Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Parkinson's Disease Treatment Market Share by Type (2014-2019)
Table Southeast Asia Parkinson's Disease Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Parkinson's Disease Treatment Market Share by Application (2014-2019)
Figure India Parkinson's Disease Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Parkinson's Disease Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Parkinson's Disease Treatment Market Share (2018-2019)
Table India Parkinson's Disease Treatment Market Size by Type (2014-2019) (Million US$)
Table India Parkinson's Disease Treatment Market Share by Type (2014-2019)
Table India Parkinson's Disease Treatment Market Size by Application (2014-2019) (Million US$)
Table India Parkinson's Disease Treatment Market Share by Application (2014-2019)
Figure Central & South America Parkinson's Disease Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Parkinson's Disease Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Parkinson's Disease Treatment Market Share (2018-2019)
Table Central & South America Parkinson's Disease Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Parkinson's Disease Treatment Market Share by Type (2014-2019)
Table Central & South America Parkinson's Disease Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Parkinson's Disease Treatment Market Share by Application (2014-2019)
Table GSK Company Details
Table GSK Revenue in Parkinson's Disease Treatment Business (2014-2019) (Million US$)
Figure GSK Revenue Growth Rate in Parkinson's Disease Treatment Business (2014-2019)
Table GSK Recent Development
Table Merck Company Details
Table Merck Revenue in Parkinson's Disease Treatment Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Parkinson's Disease Treatment Business (2014-2019)
Table Merck Recent Development
Table Novartis Company Details
Table Novartis Revenue in Parkinson's Disease Treatment Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Parkinson's Disease Treatment Business (2014-2019)
Table Novartis Recent Development
Table Teva Company Details
Table Teva Revenue in Parkinson's Disease Treatment Business (2014-2019)(Million US$)
Figure Teva Revenue Growth Rate in Parkinson's Disease Treatment Business (2014-2019)
Table Teva Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Revenue in Parkinson's Disease Treatment Business (2014-2019)(Million US$)
Figure Boehringer Ingelheim Revenue Growth Rate in Parkinson's Disease Treatment Business (2014-2019)
Table Boehringer Ingelheim Recent Development
Table Impax Company Details
Table Impax Revenue in Parkinson's Disease Treatment Business (2014-2019)(Million US$)
Figure Impax Revenue Growth Rate in Parkinson's Disease Treatment Business (2014-2019)
Table Impax Recent Development
Table Abbvie Company Details
Table Abbvie Revenue in Parkinson's Disease Treatment Business (2014-2019)(Million US$)
Figure Abbvie Revenue Growth Rate in Parkinson's Disease Treatment Business (2014-2019)
Table Abbvie Recent Development
Table Bausch Health Company Details
Table Bausch Health Revenue in Parkinson's Disease Treatment Business (2014-2019)(Million US$)
Figure Bausch Health Revenue Growth Rate in Parkinson's Disease Treatment Business (2014-2019)
Table Bausch Health Recent Development
Table Lundbeck Company Details
Table Lundbeck Revenue in Parkinson's Disease Treatment Business (2014-2019)(Million US$)
Figure Lundbeck Revenue Growth Rate in Parkinson's Disease Treatment Business (2014-2019)
Table Lundbeck Recent Development
Table Sun Pharmaceutical Industries Company Details
Table Sun Pharmaceutical Industries Revenue in Parkinson's Disease Treatment Business (2014-2019)(Million US$)
Figure Sun Pharmaceutical Industries Revenue Growth Rate in Parkinson's Disease Treatment Business (2014-2019)
Table Sun Pharmaceutical Industries Recent Development
Table Wockhardt Company Details
Table Acadia Pharmaceuticals Company Details
Table UCB Company Details
Table Global Parkinson's Disease Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Parkinson's Disease Treatment Market Size Share by Regions (2019-2025)
Figure Global Parkinson's Disease Treatment Market Size Share by Regions in 2025
Figure United States Parkinson's Disease Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Parkinson's Disease Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Parkinson's Disease Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Parkinson's Disease Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Parkinson's Disease Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Parkinson's Disease Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Parkinson's Disease Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Parkinson's Disease Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Parkinson's Disease Treatment Market Size by Product (2019-2025)
Figure Global Parkinson's Disease Treatment Market Size by Product in 2025
Table Global Parkinson's Disease Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Parkinson's Disease Treatment Market Size by Application (2019-2025)
Figure Global Parkinson's Disease Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---